Literature DB >> 15111180

A novel technique for localization and excisional biopsy of small or ill-defined pulmonary lesions.

Thomas M Daniel1, Talissa A Altes, Patrice K Rehm, Mark B Williams, David R Jones, Alexander V Stolin, Spencer B Gay.   

Abstract

BACKGROUND: The purpose of this study was to develop and evaluate radiotracer-guided localization of small or ill-defined pulmonary nodules for thoracoscopic excisional biopsy.
METHODS: This study consisted of two parts: a laboratory study in rats to determine the most suitable radiotracer, and a pilot study in humans to determine the feasibility of radiotracer lung nodule localization. The right lung of 12 rats was injected with a technetium 99m (Tc 99m) based radiotracer solution: 4 each with macroaggregated albumin (MAA), unfiltered sulfur colloid (SC), and pertechnetate (TcO(4)). Serial imaging was performed using a small animal gamma camera for 4 hours following injection. In 13 patients, computed tomographic (CT) guided injection of Tc 99m MAA solution was made into or adjacent to a pulmonary nodule suspicious for primary lung cancer. Gamma probe localization of the nodule was performed during subsequent thoracoscopic surgery.
RESULTS: In the animal model, MAA provided more precise localization than SC or TcO(4) and was selected for the human study. In the human series, all 13 patients had successful gamma probe localization of their lesion. There were no radiologic or surgical complications. Seven of 13 nodules were malignant, and five of these nodules were stage IA primary lung carcinomas.
CONCLUSIONS: Computed tomographic-guided radiotracer localization of small or ill-defined pulmonary nodules using Tc 99 m MAA before thoracoscopic excisional biopsy is feasible and may make excisional biopsy the preferred management strategy for the management of small pulmonary nodules in patients at high risk for malignancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111180     DOI: 10.1016/j.athoracsur.2003.10.099

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Intrathoracoscopic localization techniques. Review of literature.

Authors:  D Sortini; C Feo; K Maravegias; P Carcoforo; E Pozza; A Liboni; A Sortini
Journal:  Surg Endosc       Date:  2006-05-13       Impact factor: 4.584

2.  Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma.

Authors:  Tamás Györke; Attila Kollár; Gyula Bottlik; Ágota Szepesi; Imre Bodó; Tamás Masszi; Viktor Bérczi; Ildikó Garai
Journal:  Int J Hematol       Date:  2011-03-01       Impact factor: 2.490

Review 3.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

4.  99mTechnetium and methylene blue guided pulmonary nodules resections: preliminary British experience.

Authors:  Marco Nardini; Rocco Bilancia; Ian Paul; Shruti Jayakumar; Pavlos Papoulidis; Mohamed ElSaegh; Richard Hartley; Mark Richardson; Pankash Misra; Marcello Migliore; Joel Dunning
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

5.  New applications of radioguided surgery in oncology.

Authors:  Almir Galvão Vieira Bitencourt; Eduardo Nóbrega Pereira Lima; Paula Nicole Vieira Pinto; Eduardo Bruno Lobato Martins; Rubens Chojniak
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

6.  Evaluation of camera-based freehand SPECT in preoperative sentinel lymph node mapping for melanoma patients.

Authors:  Annie K Kogler; Andrew M Polemi; Surabhi Nair; Stanislaw Majewski; Lynn T Dengel; Craig L Slingluff; Brian Kross; S J Lee; J E McKisson; John McKisson; Andrew G Weisenberger; Benjamin L Welch; Thomas Wendler; Philipp Matthies; Joerg Traub; Michael Witt; Mark B Williams
Journal:  EJNMMI Res       Date:  2020-11-11       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.